Natalia Smaglyukova

Tromso, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Correction: Pharmacodynamic properties for inhibition of cAMP- and cGMP elimination by pentoxifylline remain unaltered in vitro during hypothermia.

Correction: Pharmacodynamic properties for inhibition of cAMP- and cGMP elimination by pentoxifylline remain unaltered in vitro during hypothermia.

Journal: Scandinavian journal of trauma, resuscitation and emergency medicine

Published: September 05, 2024

Moderate but not severe hypothermia increases intracellular cyclic AMP through preserved production and reduced elimination.

Moderate but not severe hypothermia increases intracellular cyclic AMP through preserved production and reduced elimination.

Journal: Cryobiology

Published: November 10, 2022

Pharmacodynamic properties for inhibition of cAMP- and cGMP elimination by pentoxifylline remain unaltered in vitro during hypothermia.

Pharmacodynamic properties for inhibition of cAMP- and cGMP elimination by pentoxifylline remain unaltered in vitro during hypothermia.

Journal: Scandinavian journal of trauma, resuscitation and emergency medicine

Published: September 16, 2022

Treatment of Cardiovascular Dysfunction with PDE3-Inhibitors in Moderate and Severe Hypothermia-Effects on Cellular Elimination of Cyclic Adenosine Monophosphate and Cyclic Guanosine Monophosphate.

Treatment of Cardiovascular Dysfunction with PDE3-Inhibitors in Moderate and Severe Hypothermia-Effects on Cellular Elimination of Cyclic Adenosine Monophosphate and Cyclic Guanosine Monophosphate.

Journal: Frontiers in physiology

Published: April 18, 2022

Treatment of Cardiovascular Dysfunction With PDE5-Inhibitors - Temperature Dependent Effects on Transport and Metabolism of cAMP and cGMP.

Treatment of Cardiovascular Dysfunction With PDE5-Inhibitors - Temperature Dependent Effects on Transport and Metabolism of cAMP and cGMP.

Journal: Frontiers in physiology

Published: April 15, 2021

Inhibition of ABCC5-mediated cGMP transport by progesterone, testosterone and their analogues.

Inhibition of ABCC5-mediated cGMP transport by progesterone, testosterone and their analogues.

Journal: The Journal of steroid biochemistry and molecular biology

Published: March 16, 2021

Data on RT-qPCR assay of nuclear progesterone receptors (nPR), membrane progesterone receptors (mPR) and progesterone receptor membrane components (PGRMC) from human uterine endometrial tissue and cancer cells of the Uterine Cervix.

Data on RT-qPCR assay of nuclear progesterone receptors (nPR), membrane progesterone receptors (mPR) and progesterone receptor membrane components (PGRMC) from human uterine endometrial tissue and cancer cells of the Uterine Cervix.

Journal: Data in brief

Published: May 14, 2020

Expression of nuclear progesterone receptors (nPRs), membrane progesterone receptors (mPRs) and progesterone receptor membrane components (PGRMCs) in the human endometrium after 6 months levonorgestrel low dose intrauterine therapy.

Expression of nuclear progesterone receptors (nPRs), membrane progesterone receptors (mPRs) and progesterone receptor membrane components (PGRMCs) in the human endometrium after 6 months levonorgestrel low dose intrauterine therapy.

Journal: The Journal of steroid biochemistry and molecular biology

Published: February 04, 2020

The role of OAT2 (SLC22A7) in the cyclic nucleotide biokinetics of human erythrocytes.

The role of OAT2 (SLC22A7) in the cyclic nucleotide biokinetics of human erythrocytes.

Journal: Journal of cellular physiology

Published: March 26, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026